奥浦迈: 奥浦迈：关于续聘公司会计师事务所的公告

Core Viewpoint - The company has decided to reappoint Lixin Certified Public Accountants as its financial audit and internal control audit institution for the year 2025, following a thorough review by the board and audit committee [1][5][7]. Group 1: Company Information - Shanghai Aopumai Biotechnology Co., Ltd. held meetings on September 1, 2025, to approve the reappointment of Lixin Certified Public Accountants [1]. - Lixin was founded in 1927 and is a member of the international accounting network BDO, with qualifications for H-share audits and registration with the PCAOB [1][2]. Group 2: Lixin's Performance and Qualifications - As of the end of 2024, Lixin had 296 partners and 2,498 registered accountants, with total business revenue of 4.748 billion yuan, including 3.672 billion yuan from audit services [2]. - Lixin has a professional risk fund of 171 million yuan and a cumulative insurance compensation limit of 1.05 billion yuan, which covers civil liability due to audit failures [2]. - In the past three years, Lixin faced five administrative penalties and 43 supervisory measures, but no criminal penalties or disciplinary actions [4]. Group 3: Audit Committee and Board Decisions - The audit committee conducted a thorough review of Lixin's qualifications, professional competence, and integrity, concluding that Lixin is well-suited to provide audit services for listed companies [5]. - The board of directors approved the reappointment of Lixin for a one-year term, pending approval from the shareholders' meeting [5][7].